| 注册
首页|期刊导航|医学分子生物学杂志|O6-MG-DNA-甲基转移酶基因表达调控及其与肿瘤耐药性的研究进展

O6-MG-DNA-甲基转移酶基因表达调控及其与肿瘤耐药性的研究进展

魏丹萍 代晓丽 罗瑛 张继虹

医学分子生物学杂志Issue(5):278-282,5.
医学分子生物学杂志Issue(5):278-282,5.DOI:10.3870/j.issn.1672-8009.2014.05.008

O6-MG-DNA-甲基转移酶基因表达调控及其与肿瘤耐药性的研究进展

Research Advances in the Regulation of O6-MG-DNA Methyltrans-ferase Gene Expression and Tumor Resistance

魏丹萍 1代晓丽 1罗瑛 1张继虹1

作者信息

  • 1. 昆明理工大学医学院衰老与肿瘤分子遗传学实验室 昆明市,650500
  • 折叠

摘要

Abstract

DNA damage and repair play an important role in gene mutations , tumorigenesis and cell death.DNA damage caused by alkylating agents is mainly repaired by O 6-methylguanine-DNA methyltransferase gene (MGMT) .The expression of MGMT in the cells is one of the main fac -tors responsible for the resistance of alkylating agents like temozolomide (TMZ) in tumors, and the correlation of MGMT promoter methylation with cancer risk and prognosis is also identi -fied.Understanding the mechanism of MGMT regulation can help to explore the DNA damage and re -pair and overcome the drug resistance of tumor.MGMT regulatory mechanism mainly consists of pro-moter methylation and histone acetylation , transcriptional and post-transcriptional regulation.

关键词

DNA 损伤修复/O6-甲基鸟嘌呤-DNA-甲基转移酶/基因表达调控/肿瘤

Key words

DNA-damage repair/O6-methylguanine-DNA methyltransferase/gene expres-sion regulation/tumor

分类

医药卫生

引用本文复制引用

魏丹萍,代晓丽,罗瑛,张继虹..O6-MG-DNA-甲基转移酶基因表达调控及其与肿瘤耐药性的研究进展[J].医学分子生物学杂志,2014,(5):278-282,5.

基金项目

国家自然科学基金( No.81260501),云南省应用基础研究计划重大项目(No.2013FC006)@@@@This work was supported by grants from the National Natural Science Foundation of China (No.81260501) and Key Projects of Applied Basic Research Plan of Yunnan Province ()

医学分子生物学杂志

OACSTPCD

1672-8009

访问量0
|
下载量0
段落导航相关论文